Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 1.00 |
| ▸ | AR | P10275 | 4/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 0.79 |
| ▸ | RAB9A | P51151 | 3/20 | 0.79 |
| ▸ | MAPT | P10636 | 2/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | MAOA | P21397 | 1/20 | 0.67 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.67 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.64 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.64 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.61 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Flavanone SCHEMBL29470801 | 1.00 | MAOB (1.00) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL19745 | 1.00 | MAOB (1.00) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL12660199 | 1.00 | MAOB (1.00) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL29843289 | 1.00 | MAOB (1.00) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL22715765 | 0.98 | MAOB (0.96) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL11733114 | 0.98 | MAOB (0.96) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL11666711 | 0.92 | MAOB (0.84) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL28795677 | 0.91 | MAOB (0.82) | MAOBARADORA3CYP19A1KDM4E | |
| Flavanone SCHEMBL31187243 | 0.90 | MAOB (0.81) | MAOBARADORA3CYP19A1KDM4E | |
| SCHEMBL12660200 | 0.89 | MAOB (0.79) | MAOBARADORA3CYP19A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025091065-A1 | FLAVONOID COMPOSITION | GRETALS AUSTRALIA PTY LTD (AU) | 2025-05-08 | — | — | WO | claimed |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | claimed |
| CN-115811969-A | Compositions and methods for preventing and treating fibrotic and inflammatory disorders | 格雷托斯澳大利亚私人有限公司 | 2023-03-17 | — | — | CN | claimed |
| EP-4146194-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | Gretals Australia Pty Ltd (AU) | 2023-03-15 | — | — | EP | claimed |
| WO-2021222987-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2021-11-11 | — | — | WO | claimed |
| WO-2021108855-A1 | NEUROLOGICALLY ACTIVE FLAVONOID COMPOSITIONS AND METHODS OF USE THEREOF | GRETALS AUSTRALIA PTY LTD (AU) | 2021-06-10 | — | — | WO | claimed |
| US-20170246353-A1 | A METHOD FOR CONSTRUCTING NITRIC OXIDE-GENERATING ADHERENT COATING | GUANGZHOU NANCHUANG EVEREST MEDICAL TECHNOLOGY CO., LTD. (CN) | 2017-08-31 | — | — | US | claimed |
| WO-2025091065-A1 | FLAVONOID COMPOSITION | GRETALS AUSTRALIA PTY LTD (AU) | 2025-05-08 | — | — | WO | disclosed |
| US-20250009709-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | INNOX Corp. (US) | 2025-01-09 | — | — | US | disclosed |
| EP-4366723-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | Innox Corp. (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-117940121-A | Isopentenylated chalcone and flavonoid compositions for the treatment of cancer | 利诺士有限公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2024017930-A1 | FRAGRANCED COSMETIC COMPOSITION COMPRISING AT LEAST ONE FLAVONOID COMPOUND, ETHANOL, A WATER-SOLUBLE COLORANT AND A FRAGRANCING SUBSTANCE | L'OREAL (FR) | 2024-01-25 | — | — | WO | disclosed |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | GRETALS AUSTRALIA PTY LTD (AU) | 2023-06-08 | — | — | US | disclosed |
| WO-2023283418-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | INNOX Corp. (US) | 2023-01-12 | — | — | WO | disclosed |
| US-11376272-B2 | Methods of modulating immune activity | FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| US-20210299155-A1 | METHODS OF MODULATING IMMUNE ACTIVITY | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-30 | — | — | US | disclosed |
| WO-2021108855-A1 | NEUROLOGICALLY ACTIVE FLAVONOID COMPOSITIONS AND METHODS OF USE THEREOF | GRETALS AUSTRALIA PTY LTD (AU) | 2021-06-10 | — | — | WO | disclosed |
| US-20200268818-A1 | BONE REMODELING ACCELERATOR | HOKURIKU UNIVERSITY (JP) | 2020-08-27 | — | — | US | disclosed |
| US-20120231972-A1 | Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the Same | INSTITUTE OF CATALYSIS (CSIC) (ES) | 2012-09-13 | — | — | US | disclosed |
| WO-2010105851-A1 | PROBE COMPOUND FOR DETECTING AND ISOLATING ENZYMES AND MEANS AND METHODS USING THE SAME | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11376272-B2 | Methods of modulating immune activity | STING1, IRF3, CGAS | MAOB 2398/4885AR 3244/4885ADORA3 37/4885 |
| US-20200268818-A1 | BONE REMODELING ACCELERATOR | SOST, COL2A1, CXCL12 | MAOB 2366/4885AR 489/4885ADORA3 837/4885 |
| US-20250009709-A1 | PRENYLATED CHALCONE AND FLAVONOID COMPOSITIONS FOR USE IN TREATING CANCER | CYP46A1, NR1H3, NR1H2 | MAOB 3147/4885AR 1683/4885ADORA3 4668/4885 |
| US-20120231972-A1 | Probe Compound for Detecting and Isolating Enzymes and Means and Methods Using the Same | SI, GUSB, MPI | MAOB 48/4885AR 3427/4885ADORA3 2034/4885 |
| US-20210299155-A1 | METHODS OF MODULATING IMMUNE ACTIVITY | STING1, IRF3, CGAS | MAOB 2989/4885AR 3497/4885ADORA3 38/4885 |
| US-20230172901-A1 | COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS | MMP1, COL1A1, SERPINB1 | MAOB 2184/4885AR 3364/4885ADORA3 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.